Trial Profile
Prospective, placebo-controlled, randomized trial investigating efficacy of palifermin in mucosal protection of previously untreated acute myeloid leukemia patients receiving combination chemotherapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2015
Price :
$35
*
At a glance
- Drugs Palifermin (Primary)
- Indications Mucositis
- Focus Pharmacodynamics; Therapeutic Use
- 05 Nov 2015 New trial record